Question

In: Finance

Plato Pharmaceuticals Ltd. has invested $100,000 to date in developing a new type of insect repellent....

Plato Pharmaceuticals Ltd. has invested $100,000 to date in developing a new type of insect repellent. The repellent is now ready for production and sale, and the marketing manager estimates that the product will sell 150,000 bottles a year for the first two years, 170,000 for year three and 200,000 for the next two years. The selling price of the insect repellent will be $6.00 a bottle and the variable costs are estimated to be $3.00 a bottle for Year one. For the next two years the selling price will be $6.50 with variable cost of $3.15 a bottle, and then selling price will be $7.00 after that with a variable cost of $3.55, and $3.80 per bottle. Fixed costs are expected to be $210,000 a year. The figure is made up of $160,000 additional fixed costs and $50,000 fixed costs relating to the existing business that will be apportioned to the new business. In order to produce the repellent, machinery and equipment costing $520,000 will have to be purchased immediately. The estimated residual (salvage) value of this machinery and equipment in five years’ time is $100,000. The business calculates depreciation following CCA rules. The business has a cost of capital of 12%. CCA 30% (50% rule applicable) of depreciation will be used, and taxes are paid at a rate of 40%. Required:

1. Create a cash flow statement for the project for the next 5 years

2. Calculate the net present value.

3. Calculate the internal rate of return.

4. Undertake sensitivity analysis to show how much the following factors would have to change before the project ceased to be feasible. a. The initial cost of machinery and equipment b. Fixed costs c. Variable costs/per bottle d. Selling Price per bottle of repellent e. The residual value of the machinery and equipment

5. Write a statement to explain which of these factors is the most sensitive one.

Solutions

Expert Solution

Question 1:

Cash Flow projection is provided in the exel sheet below

Question 2:

The net present value = $ 278,201

Question 3:

IRR = 28.2%


Related Solutions

Plato Pharmaceuticals Ltd. has invested $100,000 to date in developing a new type of insect repellent....
Plato Pharmaceuticals Ltd. has invested $100,000 to date in developing a new type of insect repellent. The repellent is now ready for production and sale, and the marketing manager estimates that the product will sell 150,000 bottles a year for the first two years, 170,000 for year three and 200,000 for the next two years. The selling price of the insect repellent will be $6.00 a bottle and the variable costs are estimated to be $3.00 a bottle for Year...
Plato Pharmaceuticals Ltd. has invested $150,000 to date in developing a new type of insect repellent....
Plato Pharmaceuticals Ltd. has invested $150,000 to date in developing a new type of insect repellent. The repellent is now ready for production and sale, and the marketing manager estimates are found in the chart below. Year Bottles per year Selling Price Variable Cost 1 150,000 $6.00 $3.00 2 165,000 $6.00 $3.15 3 175,000 $6.95 $3.25 4 190,000 $6.95 $3.55 5 190,000 $7.95 $3.60 6 170,000 $7.95 $3.90 Fixed costs (excluding amortization) are expected to be $200,000 a year. The...
4. You are visiting the rainforest, but unfortunately your insect repellent has run out. As a...
4. You are visiting the rainforest, but unfortunately your insect repellent has run out. As a result, at each second, a mosquito lands on your neck with probability 0.5. If one lands, with probability 0.2 it bites you, and with probability 0.8 it never bothers you, independently of other mosquitoes. a. What is the expected time between successive mosquito bites? What is the variance of the time between successive mosquito bites? b. In addition, a tick lands on your neck...
06. Testing a new insect repellent. (Adapted from McClave, Benson, & Sincich, 12th edition, page 556)....
06. Testing a new insect repellent. (Adapted from McClave, Benson, & Sincich, 12th edition, page 556). A study in the Journal of the American Mosquito Control Association (Mar. 1995) investigated whether a tent sprayed with a commercially available 1% permethrin formulation would protest people, both inside and outside the tent, against biting mosquitoes. Two canvas tents — one treated with permethrin, the other untreated — were position 25 meters apart on flat, dry ground in an area infested with mosquitoes....
The company that you manage has invested $5 million in developing a new product, but the...
The company that you manage has invested $5 million in developing a new product, but the development is not quite finished. At a recent meeting, your salespeople report that the introduction of competing products has reduced the expected sales of your new product to $3 million. If it would cost $1 million to finish development and make the product, you   go ahead and do so. The most you should pay to complete development is million.
A portfolio has $100,000 invested in bonds and $400,000 invested in stocks. The bonds have an...
A portfolio has $100,000 invested in bonds and $400,000 invested in stocks. The bonds have an expected return of 0.09 a with a standard deviation of 0.07. The stocks have an expected return of 0.14 with a standard deviation of 0.25. The correlation between the stocks and bonds is 0.40. (Round to 3 decimals if necessary) What is the portfolio weight for the bonds? Flag this Question Question 8 Refer to Scenario 3. What is the portfolio weight for the...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing a new drug that, if successful, would revolutionize the treatment of pancreatic and/or liver cancer. Sunset is about to start Phase I of the clinical testing for the new drug. New Dawn estimates that if they acquired Sunset the costs associated with Phase I testing would be around $60 million. They believe the probability of successful Phase I testing is 30%. Phase 2 testing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing a new drug that, if successful, would revolutionize the treatment of pancreatic and/or liver cancer. Sunset is about to start Phase I of the clinical testing for the new drug. New Dawn estimates that if they acquired Sunset the costs associated with Phase I testing would be around $60 million. They believe the probability of successful Phase I testing is 30%. Phase 2 testing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing a new drug that, if successful, would revolutionize the treatment of pancreatic and/or liver cancer. Sunset is about to start Phase I of the clinical testing for the new drug. New Dawn estimates that if they acquired Sunset the costs associated with Phase I testing would be around $60 million. They believe the probability of successful Phase I testing is 30%. Phase 2 testing...
Donald Gilmore has $100,000 invested in a 2-stock portfolio. $20,000 is invested in Stock X and...
Donald Gilmore has $100,000 invested in a 2-stock portfolio. $20,000 is invested in Stock X and the remainder is invested in Stock Y. X's beta is 1.50 and Y's beta is 0.70. What is the portfolio's beta? Zacher Co.'s stock has a beta of 1.12, the risk-free rate is 4.25%, and the market risk premium is 5.50%. What is the firm's required rate of return? Porter Plumbing's stock had a required return of 14.25% last year, when the risk-free rate...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT